281 related articles for article (PubMed ID: 28119237)
21. Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma.
Eichenmüller M; Hemmerlein B; von Schweinitz D; Kappler R
Br J Cancer; 2010 Jun; 103(1):43-51. PubMed ID: 20517313
[TBL] [Abstract][Full Text] [Related]
22. Potential mechanisms of resistance to TRAIL/Apo2L-induced apoptosis in human promyelocytic leukemia HL-60 cells during granulocytic differentiation.
Shiiki K; Yoshikawa H; Kinoshita H; Takeda M; Ueno A; Nakajima Y; Tasaka K
Cell Death Differ; 2000 Oct; 7(10):939-46. PubMed ID: 11279540
[TBL] [Abstract][Full Text] [Related]
23. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
Pollack IF; Erff M; Ashkenazi A
Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
[TBL] [Abstract][Full Text] [Related]
24. Betulinic Acid Restricts Human Bladder Cancer Cell Proliferation In Vitro by Inducing Caspase-Dependent Cell Death and Cell Cycle Arrest, and Decreasing Metastatic Potential.
Kim SY; Hwangbo H; Kim MY; Ji SY; Kim DH; Lee H; Kim GY; Moon SK; Leem SH; Yun SJ; Kim WJ; Cheong J; Park C; Choi YH
Molecules; 2021 Mar; 26(5):. PubMed ID: 33806566
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death.
Ibrahim SM; Ringel J; Schmidt C; Ringel B; Müller P; Koczan D; Thiesen HJ; Löhr M
Pancreas; 2001 Jul; 23(1):72-9. PubMed ID: 11451151
[TBL] [Abstract][Full Text] [Related]
26. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells.
Hao C; Beguinot F; Condorelli G; Trencia A; Van Meir EG; Yong VW; Parney IF; Roa WH; Petruk KC
Cancer Res; 2001 Feb; 61(3):1162-70. PubMed ID: 11221847
[TBL] [Abstract][Full Text] [Related]
27. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
Ahmad M; Shi Y
Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593
[TBL] [Abstract][Full Text] [Related]
28. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
29. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.
Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O
Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609
[TBL] [Abstract][Full Text] [Related]
30. Betulinic acid triggers apoptosis and inhibits migration and invasion of gastric cancer cells by impairing EMT progress.
Chen Y; Wu X; Liu C; Zhou Y
Cell Biochem Funct; 2020 Aug; 38(6):702-709. PubMed ID: 32283563
[TBL] [Abstract][Full Text] [Related]
31. Glioma progression is suppressed by Naringenin and APO2L combination therapy via the activation of apoptosis in vitro and in vivo.
Song T; Zhang M; Wu J; Chen F; Wang Y; Ma Y; Dai Z
Invest New Drugs; 2020 Dec; 38(6):1743-1754. PubMed ID: 32767162
[TBL] [Abstract][Full Text] [Related]
32. Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing.
Wick W; Grimmel C; Wagenknecht B; Dichgans J; Weller M
J Pharmacol Exp Ther; 1999 Jun; 289(3):1306-12. PubMed ID: 10336521
[TBL] [Abstract][Full Text] [Related]
33. Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9.
Takada Y; Aggarwal BB
J Immunol; 2003 Sep; 171(6):3278-86. PubMed ID: 12960358
[TBL] [Abstract][Full Text] [Related]
34. Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infection.
Brost S; Zimmermann A; Koschny R; Sykora J; Stremmel W; Schirmacher P; Walczak H; Ganten TM
Pathol Res Pract; 2014 Feb; 210(2):83-91. PubMed ID: 24268735
[TBL] [Abstract][Full Text] [Related]
35. TRAIL receptor signalling and modulation: Are we on the right TRAIL?
Mahalingam D; Szegezdi E; Keane M; de Jong S; Samali A
Cancer Treat Rev; 2009 May; 35(3):280-8. PubMed ID: 19117685
[TBL] [Abstract][Full Text] [Related]
36. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
Kim JH; Ajaz M; Lokshin A; Lee YJ
Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
[TBL] [Abstract][Full Text] [Related]
37. Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells.
Fulda S; Jeremias I; Debatin KM
Oncogene; 2004 Oct; 23(46):7611-20. PubMed ID: 15361826
[TBL] [Abstract][Full Text] [Related]
38. Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo.
Shankar S; Chen X; Srivastava RK
Prostate; 2005 Feb; 62(2):165-86. PubMed ID: 15389801
[TBL] [Abstract][Full Text] [Related]
39. Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity.
O'Leary L; van der Sloot AM; Reis CR; Deegan S; Ryan AE; Dhami SP; Murillo LS; Cool RH; Correa de Sampaio P; Thompson K; Murphy G; Quax WJ; Serrano L; Samali A; Szegezdi E
Oncogene; 2016 Mar; 35(10):1261-70. PubMed ID: 26050621
[TBL] [Abstract][Full Text] [Related]
40. Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78.
Cai Y; Zheng Y; Gu J; Wang S; Wang N; Yang B; Zhang F; Wang D; Fu W; Wang Z
Cell Death Dis; 2018 May; 9(6):636. PubMed ID: 29802332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
